MDD Revision Clarifies Existing Policies, Tightens Industry Loopholes
This article was originally published in The Gray Sheet
Executive Summary
A draft revision of the European Medical Devices Directive would give manufacturers of implantable and Class III devices less leeway to avoid clinical evaluation requirements
You may also be interested in...
Medtronic’s EU e-Labeling Pilot Study Aims To Sway European Policymakers
Medtronic is conducting a European pilot study of its electronic product manuals to demonstrate feasibility and user advantages of e-labeling
Medtronic’s EU e-Labeling Pilot Study Aims To Sway European Policymakers
Medtronic is conducting a European pilot study of its electronic product manuals to demonstrate feasibility and user advantages of e-labeling
Combo Products Face Costlier Process Under Europe’s New MDD – Alcon Exec
The combination product policy outlined in the proposed revisions to Europe's Medical Devices Directive is emerging as a leading industry concern